Department of Neurosurgery, The Aga Khan University, Karachi, Pakistan.
Department of Oncology, Aga Khan University Hospital, Pakistan.
J Pak Med Assoc. 2024 Mar;74(3 (Supple-3)):S100-S108. doi: 10.47391/JPMA.S3.GNO-12.
High-grade glioma (HGG), a formidable and often incurable disease, presents an even greater challenge in low- and middle-income countries (LMICs) where resources and medical expertise are scarce. This scarcity not only exacerbates the suffering of patients but also contributes to poorer clinical outcomes. Particularly in LMICs, the underrepresentation of the population in clinical trials and the additional hurdles posed by financial constraints underscore an urgent need for contextspecific management strategies. In response, we have rigorously evaluated recent guidelines from leading medical societies, adapting them to suit the specific needs and limitations of the local context in Pakistan. This effort, undertaken in collaboration with local physicians, aims to provide a comprehensive, standardised approach to diagnose, treat, and follow-up with HGG patients. By focussing on the best available clinical evidence and judicious use of limited resources, we strive to improve patient care and outcomes in these challenging settings.
高级别胶质瘤(HGG)是一种严重且往往无法治愈的疾病,在资源和医疗专业知识匮乏的中低收入国家(LMICs)面临更大的挑战。这种匮乏不仅加剧了患者的痛苦,还导致了更差的临床结局。特别是在 LMICs 中,临床试验中代表性不足以及财务限制带来的额外障碍突显了制定特定于具体情况的管理策略的迫切需要。有鉴于此,我们对来自主要医学协会的最新指南进行了严格评估,并根据巴基斯坦当地的具体需求和限制对其进行了调整。这项与当地医生合作开展的工作旨在为 HGG 患者的诊断、治疗和随访提供一种全面、标准化的方法。通过关注最佳的现有临床证据并明智地利用有限的资源,我们努力改善这些具有挑战性环境中的患者护理和结局。